Search

Your search keyword '"Tsubota Noriaki"' showing total 403 results
Start Over Author "Tsubota Noriaki"
403 results on '"Tsubota Noriaki"'

2. MUTYH Gln324His gene polymorphism and genetic susceptibility for lung cancer in a Japanese population

Author

Tsutou Akimitsu, Kasahara Mayumi, Yoshida Kana, Inoue Natsuko, Osawa Yasunori, Osawa Kayo, Miyaishi Aiko, Tabuchi Yoshiki, Sakamoto Kazuo, Tsubota Noriaki, and Takahashi Juro

Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Abstract Background Genetic polymorphisms of DNA repair enzymes in the base excision repair (BER) pathway, may lead to genetic instability and lung cancer carcinogenesis. We investigated the interactions among the gene polymorphisms in DNA repair genes and lung cancer. Methods We analyzed associations among OGG1 Ser326Cys and MUTYH Gln324His gene polymorphisms in relation to lung cancer risk using PCR-RFLP. The study involved 108 lung cancer patients and 121 non-cancer controls divided into non-smokers, smokers according to pack-years smoked in Japanese. Results The results showed that the MUTYH His/His genotype compared with Gln/Gln genotype showed an increased risk for lung cancer (adjusted odds ratio [OR] 3.03, confidence interval [95%CI], 1.31–7.00, p = 0.010), whereas there was no significant increase for the Gln/His genotype (adjusted OR 1.35, 95%CI 0.70–2.61, p = 0.376). The MUTYH His/His genotype was at a borderline increased risk for both adenocarcinoma and squamous cell carcinoma (adjusted OR 2.50, 95%CI 0.95–6.62, p = 0.065 for adenocarcinoma; adjusted OR 3.20, 95%CI 0.89–11.49, p = 0.075 for squamous cell carcinoma, respectively). However, the OGG1 Ser/Cys or Cys/Cys genotypes compared with the Ser/Ser genotype did not have significantly increased risk for lung cancer, containing either adenocarcinoma or squamous cell carcinoma. The joint effect of tobacco exposure and the MUTYH His/His genotype compared with the Gln/Gln genotype showed a significant association with lung cancer risk in smokers, and there was not significantly increased in non-smokers (adjusted OR 3.82, 95%CI 1.22–12.00, p = 0.022 for smokers; adjusted OR 2.60, 95%CI 0.60–11.25, p = 0.200 for non-smokers, respectively). The effect of tobacco exposure and the OGG1 Ser326Cys showed also no significant risk for lung cancer. Conclusion Our findings suggest that the MUTYH Gln324His polymorphism appear to play an important role in modifying the risk for lung cancer in the Japanese population.

Published
2009
Full Text
View/download PDF

13. A randomized trail of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung

Author

Kato, Harubumi, Ichinose, Yukito, Ohata, Morio, Hata, Enjo, Tsubota, Noriaki, Tada, Hirohito, Watanabe, Yoh, Wada, Hiromi, Tsuboi, Masahiro A, Ohata, Mitsuo, and Hamajima, Nobuyuki

Subjects
Cancer -- Adjuvant treatment, Cancer -- Usage, Antineoplastic agents -- Dosage and administration, Antimitotic agents -- Dosage and administration, Lung cancer -- Care and treatment
Abstract

The study showing that adjuvant chemotherapy with uracil-tegafur has a beneficial effect on the survival of patients with resected stage one adenocarcinoma of the lungs, is presented.

Published
2004

Catalog

Books, media, physical & digital resources
See catalog results